Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1959 Aug;38(8):1349–1355. doi: 10.1172/JCI103910

COMBINED DRUG TREATMENT OF TUBERCULOSIS. I. PREVENTION OF EMERGENCE OF MUTANT POPULATIONS OF TUBERCLE BACILLI RESISTANT TO BOTH STREPTOMYCIN AND ISONIAZID IN VITRO

Maurice L Cohn 1,2,3, Gardner Middlebrook 1,2,3, William F Russell Jr 1,2,3
PMCID: PMC442089  PMID: 13673091

Full text

PDF
1349

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. COHN M. L., KOVITZ C., ODA U., MIDDLEBROOK G. Studies on isoniazid and tubercle bacilli. II. The growth requirements, catalase activities, and pathogenic properties of isoniazid-resistant mutants. Am Rev Tuberc. 1954 Oct;70(4):641–664. doi: 10.1164/art.1954.70.4.641. [DOI] [PubMed] [Google Scholar]
  2. COHN M. L., ODA U., KOVITZ C., MIDDLEBROOK G. Studies on isoniazid and tubercle bacilli. I. The isolation of isoniazid-resistant mutants in vitro. Am Rev Tuberc. 1954 Sep;70(3):465–475. doi: 10.1164/art.1954.70.3.465. [DOI] [PubMed] [Google Scholar]
  3. Demerec M. Origin of Bacterial Resistance to Antibiotics. J Bacteriol. 1948 Jul;56(1):63–74. doi: 10.1128/jb.56.1.63-74.1948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. LEWIN E., HIRSCH J. G. Studies on the stability of isoniazid. Am Rev Tuberc. 1955 May;71(5):732–742. doi: 10.1164/artpd.1955.71.5.732. [DOI] [PubMed] [Google Scholar]
  5. MIDDLEBROOK G., COHN M. L., SCHAEFER W. B. Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients. Am Rev Tuberc. 1954 Nov;70(5):852–872. doi: 10.1164/art.1954.70.5.852. [DOI] [PubMed] [Google Scholar]
  6. MIDDLEBROOK G. Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro. Am Rev Tuberc. 1952 Jun;65(6):765–767. [PubMed] [Google Scholar]
  7. MOUNT F. W., FEREBEE S. H. United States Public Health service cooperative investigation of antimicrobial therapy of tuberculosis, V. Report on thirty-two-week observations on combinations of isoniazid, streptomycin, and para-aminosalicylic acid. Am Rev Tuberc. 1954 Sep;70(3):521–526. doi: 10.1164/art.1954.70.3.521. [DOI] [PubMed] [Google Scholar]
  8. MOUNT F. W., JENKINS B. E., FEREBEE S. H. Control study of comparative efficacy of isoniazid, streptomycin-isoniazid, and streptomycin; para-aminosalicylic acid in pulmonary tuberculosis therapy. IV. Report on forty-week observations on 583 patients with streptomycin susceptible infections. Am Rev Tuberc. 1953 Aug;68(2):264–269. doi: 10.1164/art.1953.68.2.264. [DOI] [PubMed] [Google Scholar]
  9. SINGH B., MITCHISON D. A. Bactericidal activity of streptomycin and isoniazid against tubercle bacilli. Br Med J. 1954 Jan 16;1(4854):130–132. doi: 10.1136/bmj.1.4854.130. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES